Ischemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems.
View Top Employees from IschemixWebsite | http://www.ischemix.com |
Revenue | $1 million |
Funding | $6.6 million |
Employees | 5 (5 on RocketReach) |
Founded | 1999 |
Address | Great Road, Maynard, Massachusetts 01754, US |
Phone | (508) 839-2999 |
Technologies |
JavaScript,
HTML,
PHP
+6 more
(view full list)
|
Industry | Biotechnology Research, Manufacturing General, Clinical Trials, Biotechnology, Manufacturing, Health Care, Other Pharmaceuticals and Biotechnology, Medical |
Web Rank | 23 Million |
Keywords | Ischemix |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Ischemix employee's phone or email?
The Ischemix annual revenue was $1 million in 2024.
David DeWahl is the President and Chief Executive Officer of Ischemix.
5 people are employed at Ischemix.
Ischemix is based in Maynard, Massachusetts.
The NAICS codes for Ischemix are [325, 32, 3254, 32541].
The SIC codes for Ischemix are [283, 28].